Machine Learning and Deep learning for Diabetic Retinopathy Detection: A Review

Computer Engineering

Diabetic retinopathy (DR) is a prevalent and serious consequence of diabetes, affecting individuals worldwide, particularly in regions with limited access to technology and financial resources. The impact of DR on vision loss underscores the urgent need for early detection and intervention. DR is typically categorized into five stages, each indicative of varying degrees of retinal damage. The first stage is known as "no DR," denoting the absence of detectable damage to the retina. Following this stage, there are four progressive levels of severity: mild, moderate, severe, and proliferative DR. In this regard, artificial intelligence (AI) and deep learning technologies have emerged as invaluable tools in ophthalmology, offering automated solutions to complement traditional approaches. The integration of AI and deep learning into the diagnosis and monitoring of DR offers numerous benefits. These technologies can automate the screening process, allowing for early identification and timely intervention. By analyzing medical images, such as retinal scans, AI algorithms can detect subtle abnormalities and provide accurate assessments of disease progression. This not only enhances the efficiency of healthcare professionals but also ensures that patients receive appropriate treatment at the earliest possible stage. Artificial intelligence and deep learning techniques offer a transformative approach to automate the process, improving the accuracy, efficiency, and accessibility of DR diagnosis. By integrating these technologies into ophthalmology practices, we can make significant strides in reducing vision loss and improving the overall quality of care for individuals affected by diabetic retinopathy.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.